Chlamydia pneumoniae

Chlamydia pneumoniae has been studied in 3 papers since 2023: 2 observational studies in people; 1 in the past year. The newest paper, May 11, 2026: “Beyond association: A quantitative analysis of the infectious burden in Alzheimer's disease”.

Exposure

3 papers study it1 findingUpdated

See all 3 papers on chlamydia pneumoniae

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

“C. pneumoniae serology was associated with impaired performance on language testing”
The association of common infectious exposures with cognitive performance in community-dwelling older adultsAlzheimer's & dementia : the journal of the Alzheimer's Association2025doi:10.1002/alz.70457
Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • Funders: National Institute of Neurological Disorders and Stroke and 2 more
  • Humans2
  • In silico1

What did studies of chlamydia pneumoniae find?

1

Studies of chlamydia pneumoniae measured one outcome, language performance.

Language performance

downin humans1

1 study
  1. Chlamydia pneumoniae is linked with worse language performance in humans (confounder-adjusted mixed linear regression).

    “C. pneumoniae serology was associated with impaired performance on language testing”

    Humansconfounder-adjusted mixed linear regression

    The association of common infectious exposures with cognitive performance in community-dwelling older adults

    Alzheimer's & dementia : the journal of the Alzheimer's Association

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 1Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months